Clinical Trials
19 trialsNCT01868087 2026-04-15
Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study
University of Kansas Medical Center
Phase EARLY_PHASE1 Completed
NCT04018053 2026-01-27
18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy
Brigham and Women's Hospital
Phase EARLY_PHASE1 Active not recruiting
NCT04897763 2026-01-07
PERTINENCE
Institut Cancerologie de l'Ouest
Phase EARLY_PHASE1 Completed
NCT04369560 2025-12-17
Virtual Histology of the Bladder Wall for Bladder Cancer Staging
University of Pittsburgh
Phase EARLY_PHASE1 Recruiting
NCT03837821 2025-11-18
CLONEVO
Weill Medical College of Cornell University
Phase EARLY_PHASE1 Active not recruiting
NCT05559177 2022-09-29
An Open, Dose-escalation Clinical Study of Chimeric Exosomal Tumor Vaccines for Recurrent or Metastatic Bladder Cancer
Shanghai Pudong Hospital
Phase EARLY_PHASE1 Unknown
NCT03204266 2022-08-24
Oral Supplementation to Enhance Recovery Pilot Study
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT03266900 2022-04-20
RESECT
University Health Network, Toronto
Phase EARLY_PHASE1 Terminated
NCT05180851 2022-02-01
YSCH-01
Shanghai Fengxian District Central Hospital
Phase EARLY_PHASE1 Unknown
NCT01738815 2021-10-22
Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer
State University of New York - Upstate Medical University
Phase EARLY_PHASE1 Completed
NCT05022160 2021-08-26
Preventing Catheter Related Bladder Discomfort (CRBD) With Bilateral Pudendal Nerve Block
Armed Forces Hospital, Pakistan
Phase EARLY_PHASE1 Unknown
NCT02753309 2021-03-19
A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer
The University of Texas Health Science Center at San Antonio
Phase EARLY_PHASE1 Completed
NCT02646319 2019-06-06
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT01261299 2018-01-09
Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer
University of California, Davis
Phase EARLY_PHASE1 Terminated
NCT02326168 2017-01-25
PRIME: Pilot Study Evaluating Percutaneous Vaccination of BCG for Bladder Cancer
The University of Texas Health Science Center at San Antonio
Phase EARLY_PHASE1 Completed
NCT02505516 2015-07-22
BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS
University of Cape Coast
Phase EARLY_PHASE1 Completed
NCT02139371 2014-12-12
Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography
Rigshospitalet, Denmark
Phase EARLY_PHASE1 Completed
NCT01240824 2014-04-14
BCG
University of Virginia
Phase EARLY_PHASE1 Completed
NCT01245660 2013-01-11
LAPAINBLAD
University Hospital, Bordeaux
Phase EARLY_PHASE1 Terminated